A5100599513- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Liver Disease Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Tumors and Oncological Cases
- Hepatitis B Virus Studies
- Neuroblastoma Research and Treatments
- Lung Cancer Research Studies
- Bone Tumor Diagnosis and Treatments
- Lung Cancer Treatments and Mutations
- RNA modifications and cancer
- Ferroptosis and cancer prognosis
- Testicular diseases and treatments
- Renal and related cancers
- Building Energy and Comfort Optimization
- Liver Disease and Transplantation
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Mechanisms and Therapy
- Blood disorders and treatments
- Liver physiology and pathology
- Lymphoma Diagnosis and Treatment
- Bacterial Identification and Susceptibility Testing
Hangzhou Medical College
2021-2025
Zhejiang Provincial People's Hospital
2019-2025
Beijing Tongren Hospital
2013-2024
Capital Medical University
2013-2024
Soochow University
2024
Guangdong University Of Finances and Economics
2024
Guangdong University of Education
2024
Sichuan University
2022-2023
Eastern Hepatobiliary Surgery Hospital
2022
Second Military Medical University
2022
Nutritional and inflammatory status has been reported to be associated with the prognosis of hepatocellular carcinoma (HCC), but many studies did not include all biomarkers simultaneously. The present study aimed determine impact Naples prognostic score (NPS) on long-term survival in patients undergoing hepatectomy for HCC.Patients HCC after curative resection were eligible. Then, stratified into three groups according NPS. Clinical features outcomes compared among groups. Independent...
Lan-Qing YAO, Hai-Bo QIU, Jia-Le PU, Yong-Kang DIAO, Chao LI, Timothy M. PAWLIK, Wan Yee LAU, Dong-Sheng HUANG, Feng SHEN, Tian YANG*. Ann Hepatobiliary Pancreat Surg 2022;26:S302. https://doi.org/10.14701/ahbps.2022S1.EP-20
High alpha-fetoprotein (AFP) expressions (>400 ng/mL) are associated with poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis after liver resection high-AFP HCC is poorly studied. To investigate long-term recurrence and survival hepatectomy HCC, to identify the predictive value of postoperative incomplete biomarker response (IBR) on overall (OS) recurrence-free (RFS).Patients undergoing curative were analyzed. According decline magnitude serum AFP as...
Objective: To explore clinical experience and propose new ideas for treating children diagnosed with orbital rhabdomyosarcoma (RMS). Methods: We retrospectively analyzed the data for30 patients (16 males 14 females, a median age of 6.2 years) primary RMS who were enrolled in Department Eye Oncology Pediatrics our hospital from November 2004 to December 2012. International Rhabdomyosarcoma Organization Staging Standards indicated that among 30 patients, 4 cases phase II, 20 III, 6 IV. All...
Abstract Background The aim of the present study was to summarize clinical characteristics in children aged under 3 years and analyze related factors affecting prognosis. Methods data 316 (192 males 124 females) who were admitted Beijing Tongren Hospital with a pathological diagnosis HB between May 2005 2019 analyzed retrospectively. influencing therapeutic effects on survival analyzed. Results (1) median age enrolled patients 1.45 years. most common initial symptom an abdominal mass...
Although anatomical hepatectomy (AH) is widely used in the treatment of hepatocellular carcinoma (HCC), prognosis still unsatisfactory. The present study aimed to evaluate survival benefit adjuvant transcatheter arterial chemoembolization (TACE) for patients with HCC after AH.A total 832 were stratified into TACE (443, 53.2%) and without group (389, 46.8%) AH. Propensity score matching (PSM) was performed control confounding factors, multivariable Cox regression determine independent risk...
Abstract The success of treating a wide variety pediatric diseases with HSCT , hematologic malignancies in particular, has resulted an increased number long‐term survivors. This study is the first large‐scale, multicentre report that describes evolution s C hina during period 1998–2012. Of all 1052 patients, 266 cases were treated autologous HSC and 786 used allogeneic s. disease indications for mainly included leukemias, lymphoma, solid tumors, non‐malignant disorders. total s, especially...
Objective After a complete remission to treatment for hepatoblastoma, some children still have recurrence. We identified and explored the factors that influence recurrence after in retrospective study. Methods Of 197 with 140 (71.1%) achieved initial were enrolled factor analysis. Variables consisted of age, sex, PRE-Treatment EXTent tumor (PRETEXT) stage, pathologic type, metastatic disease, serum alpha-fetoprotein level, vascular involvement, surgical margin status. employed univariate...
Background: Despite significant advances in tumor immunotherapy, hepatocellular carcinoma (HCC) remains a malignancy with challenging prognosis.The increasing research emphasizes the crucial role of ubiquitination immunotherapy.However, establishment prognostic signatures based on ubiquitination-related genes (UbRGs) and their immunotherapy are still lacking HCC.Methods: We employed datasets from TCGA GEO for transcriptome differential expression analysis single-cell RNA sequencing...
Integrating the education of traditional Chinese culture with teaching chemical knowledge has become a significant focus chemistry education. Home experiments, which use simple explorations common household items, play crucial role in enhancing students' comprehension and application textbook knowledge. This study explores fusion home focusing on integrating Peking opera facial makeup paper-cutting into anthocyanin's color changing experiment. are recognized as forms art that can be...
Undifferentiated embryonal sarcoma of the liver (UESL) very rarely presents clinically. Approximately 1% to 4% all solid tumors in children are malignant tumors, and UESL accounts for 9% 15% tumor. The onset usually occurs at 6 10 years age there is no obvious difference based on sex.[1] first symptoms abdominal distention pain without jaundice, while a physical examination commonly reveals positive vital signs except palpable tumor.[1] serum alpha-fetoprotein (AFP) test not sensitive...
Hepatoblastoma is a malignant liver tumor generally diagnosed in infants and children <3 years old. The current retrospective study aimed to investigate the associations of stage, pathological type, metastasis chemotherapy with clinical outcomes. In study, total 102 patients hepatoblastoma were enrolled between September 2006 June 2014. Clinical records follow‑up information for each patient obtained conduct Kaplan‑Meier survival analysis log‑rank test. median age subjects was 1.5 years, 98...
Abstract Background This study explores and analyzes the clinical characteristics prognostic factors of hepatoblastoma (HB) in children under 6 years old establishes a new risk-stratification system for individualized therapy. Methods The data 382 pediatric patients (231 males 151 females) who had been diagnosed with HB by pathology between May 2005 2019 were collected. By analyzing risk influencing survival rate HB, was established, it compared previous systems receiver operating...